Table 1.
Position | Sequence | No. of hybridomas |
---|---|---|
116–130 | MNILLQYVVKSFDRST | 8 |
271–285 | PRLIAFTSEHSHFSL | 31* |
PRLIAFTSEHSHFSL | ||
356–370 | KYKIWMHVDAAWGGG | 1 |
376–390 | KHKWKLSGVERANSV | 1 |
481–495 | LYNIIKNREGYEMVF | 19 |
511–525 | PSLRTLEDNEERMSR | 8 |
546–560 | SYQPLGDKVNFFRMV | 1 |
551–565 | GDKVNFFRMVISNPA | 14† |
556–570 | FFRMVISNPAATHQD | |
566–580 | ATHQDIDFLIEEIER | 1 |
For each peptide, the sequence and the number of responding hybridomas is shown. Boldface sequences mark experimentally defined core immunogenic sequence.
Refers to p271–285, which contains both epitopes.
All 14 hybridomas respond to p551–565 and p566–580.